By using WellRx, you accept our Privacy Policy (including the CA Privacy Act policy if you are a CA resident), including our collection of data and use of cookies.

RISPERIDONE (ris PER i done) treats schizophrenia, bipolar disorder, and autism spectrum disorder. It works by balancing the levels of dopamine and serotonin in your brain, substances that help regulate mood, behaviors, and thoughts. It belongs to a group of medications called antipsychotics. Antipsychotic medications can be used to treat several kinds of mental health conditions.

RISPERIDONE ODT Lifestyle Interactions

  • Alfuzosin 10mg, Oral tablet, extended release

    • Interaction: Grapefruit juice
    • Severity: Major
    • Notes for Consumers: Do not drink grapefruit juice or eat grapefruit while taking this medication. Grapefruit may alter the effects of your medication. Serious side effects may occur. Contact your care team right away if you experience new or worsening side effects.
    • Notes for Professionals: Advise patients to avoid grapefruit and grapefruit juice during alfuzosin treatment due to the risk for increased alfuzosin exposure and adverse reactions. Alfuzosin is a CYP3A substrate and grapefruit juice is a CYP3A inhibitor.

  • Alfuzosin 10mg, Oral tablet, extended release

    • Interaction: Food
    • Severity: Moderate
    • Notes for Consumers: Alfuzosin should be taken with food at the same time each day. Try to take Alfuzosin with the same meal each day. Selected foods might interact with Alfuzosin. Grapefruit juice may increase blood levels of Alfuzosin by reducing Alfuzosin metabolism in the body. Too much Alfuzosin in the blood can lower the blood pressure. If the blood pressure drops too low, you may become dizzy or feel faint. To limit this interaction, it is probably best not to greatly change your intake of grapefruit or grapefruit juice while taking Alfuzosin.
    • Notes for Professionals: Alfuzosin extended-release tablets should be taken with food at the same time each day. Alfuzosin absolute bioavailability is 49 percent under fed conditions; under fasting conditions, the extent of absorption is 50 percent lower.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.